Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00520312 · ClinicalTrials.gov registry record
Magnetic Resonance Imaging to Identify Characteristics of Plaque Build-Up in People With Peripheral Arterial Disease
A clinical trial of Peripheral Vascular Diseases, sponsored by Northwestern University.
- Completed
- Registry status
- 519
- Enrollment target
- 1
- Study location
NCT00520312: Completed study of Peripheral Vascular Diseases, sponsored by Northwestern University.
NCT00520312 is a study of Peripheral Vascular Diseases that has completed, run by Northwestern University. The registered enrollment target is 519 participants, above the 469-participant average among 19 other Peripheral Vascular Diseases trials with a reported enrollment target (11% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00520312, a study of Peripheral Vascular Diseases, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 519 participants
- Enrollment target
- 1
- Study location
Study Summary
Peripheral arterial disease (PAD) is a disease in which fatty build-up, or "plaque," accumulates in the peripheral arteries. People with PAD often experience leg pain while walking due to reduced blood flow to the legs. This study will use magnetic resonance imaging (MRI) techniques to examine how specific features of plaque build-up in the leg arteries affect walking ability, leg strength, and balance in people with PAD.
Conditions Studied
Study Locations (1)
Illinois
- Northwestern University - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 519 participants |
| Start Date | 2007-10 |
| Est. Completion | 2012-01 |
What the finished NCT00520312 record still lists
NCT00520312 is an observational study that tracks outcomes without assigning an intervention. The registered 519 participants enrollment target is mid-sized for trials with a published cap, above the 469-participant average among 19 other Peripheral Vascular Diseases trials with a reported enrollment target (11% higher).
The record links to 1 condition, with Peripheral Vascular Diseases appearing as the primary indexed condition, and to 0 interventions.
NCT00520312 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT00520312 about?
NCT00520312 is a clinical study titled "Magnetic Resonance Imaging to Identify Characteristics of Plaque Build-Up in People With Peripheral Arterial Disease". Peripheral arterial disease (PAD) is a disease in which fatty build-up, or "plaque," accumulates in the peripheral arteries. People with PAD often experience leg pain while walking due to reduced blood flow to the legs. This study will use magnetic resonance imaging (MRI) techniques to examine how s...
What is the current status of trial NCT00520312?
This trial is currently completed. The enrollment target is 519 participants. The study started on 2007-10. Estimated completion is 2012-01.
What conditions does trial NCT00520312 study?
This clinical trial studies the following conditions: Peripheral Vascular Diseases.
Who is sponsoring clinical trial NCT00520312?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00520312 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peripheral Vascular Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00520312's enrollment target sits among peer trials
519 4th of 19 higher than 16 of 19 other Peripheral Vascular Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Peripheral Vascular Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Effects of ATLAS Therapy on Nitric Oxide Bioavailability in Patients With Intermittent Claudication
RECRUITING · Phase 1
-
Randomized Controlled Trial of Alert-Based Computerized Decision Support for Patients With Peripheral Artery Disease Not Prescribed Lipid-Lowering Therapy
RECRUITING · NA
-
Impact of Nrf2 Activation on Macrovascular, Microvascular & Leg Function & Walking Capacity in Peripheral Artery Disease
RECRUITING · Early Phase 1
-
MRI Guided Management of Occlusive Peripheral Arterial Disease
RECRUITING
-
Examining the Impact of Exercise Training on Vascular Dysfunction in Individuals With Mental Health Disorders - Study 2
RECRUITING · NA
-
Fisetin to Reduce Senescence and Mobility Impairment in PAD
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323581 · 520 participants · NA
Endovascular Treatment of TAAA and Aortic Arch Aneurysms Using Fenestrated and Branched Stent Grafts
- NCT04656496 · 520 participants · NA
NOURISH-T+: Promoting Healthy Eating and Exercise Behaviors
- NCT05445778 · 520 participants · Phase 3
Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer
- NCT05498428 · 520 participants · Phase 2
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia